Ir a la página de inicio del Gobierno del Principado de Asturias

Datos del Documento

Utilice este identificador para citar o enlazar este documento: https://ria.asturias.es/RIA/handle/123456789/52


Título: Oral active vitamin D is associated with improved survival in hemodialysis patients
Autores: Naves-Díaz, Manuel
Álvarez Hernández, Daniel
Passlick-Deetjen, Jutta
Guinsburg, Adrian
Marelli, Cristina
Rodríguez Puyol, Diego
Cannata Andía, Jorge B.
Palabras Claves: Hemodialysis
Mortality
Oral calcitriol
Latin America
Fecha Edición: Jul-2008
Editor: International Society of Nephrology
Cita Bibliográfica: Naves Díaz Manuel, Alvarez Hernández Daniel, Passlick Deetjen Jutta, Guinsburg Adrian, Marelli Cristina, Rodriguez Puyol Diego, Cannata Andía Jorge. Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney International;2008(74):1070–1078
Resumen: Injection of active vitamin D is associated with better survival of patients receiving chronic hemodialysis. Since in many countries oral active vitamin D administration is the most common form of treatment for secondary hyperparathyroidism we determined the survival benefit of oral active vitamin D in hemodialysis patients from six Latin America countries (FME Register as part of the CORES study) followed for a median of 16 months. Time-dependent Cox regression models, after adjustment for potential confounders, showed that the 7,203 patients who received oral active vitamin D had significant reductions in overall, cardiovascular, infectious and neoplastic mortality compared to the 8,801 patients that had not received vitamin D. Stratified analyses found a survival advantage in the group that had received oral active vitamin D in 36 of the 37 strata studied including that with the highest levels of serum calcium, phosphorus and parathyroid hormone. The survival benefit of oral active vitamin D was seen in those patients receiving mean daily doses of less than 1 microg with the highest reduction associated with the lowest dose. Our study shows that hemodialysis patients receiving oral active vitamin D had a survival advantage inversely related to the vitamin dose.
URI: https://ria.asturias.es/RIA/handle/123456789/52
Aparece en las Colecciones:Sanidad
Open Access DRIVERset

Archivos en este documento:



Archivo TamañoFormato
Archivo.pdf190,39 kBAdobe PDFVer/Abrir



logo

Todos los documentos en RIA están protegidos por derechos de autor.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard - Contacto